[DPHARMA] YoY Quarter Result on 30-Jun-2016 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-Aug-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Jun-2016 [#2]
Profit Trend
QoQ- -42.59%
YoY- -23.0%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 145,466 123,991 117,049 79,135 56,308 40,623 37,988 25.06%
PBT 18,316 12,915 12,642 7,723 8,407 10,107 13,007 5.86%
Tax -4,400 -2,576 -3,001 -3,782 -2,559 -2,594 -2,318 11.26%
NP 13,916 10,339 9,641 3,941 5,848 7,513 10,689 4.49%
-
NP to SH 13,916 10,339 9,653 4,503 5,848 7,513 10,689 4.49%
-
Tax Rate 24.02% 19.95% 23.74% 48.97% 30.44% 25.67% 17.82% -
Total Cost 131,550 113,652 107,408 75,194 50,460 33,110 27,299 29.94%
-
Net Worth 503,029 209,983 463,071 446,334 189,815 179,145 187,404 17.87%
Dividend
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Div 6,618 4,199 6,973 6,973 5,582 5,554 5,552 2.96%
Div Payout % 47.56% 40.62% 72.25% 154.87% 95.47% 73.94% 51.95% -
Equity
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Net Worth 503,029 209,983 463,071 446,334 189,815 179,145 187,404 17.87%
NOSH 661,881 650,902 278,959 278,959 139,570 138,872 138,818 29.71%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin 9.57% 8.34% 8.24% 4.98% 10.39% 18.49% 28.14% -
ROE 2.77% 4.92% 2.08% 1.01% 3.08% 4.19% 5.70% -
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
RPS 21.98 44.29 41.96 28.37 40.34 29.25 27.37 -3.58%
EPS 2.07 1.59 3.46 1.41 4.19 5.41 7.70 -19.65%
DPS 1.00 1.50 2.50 2.50 4.00 4.00 4.00 -20.62%
NAPS 0.76 0.75 1.66 1.60 1.36 1.29 1.35 -9.12%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
RPS 15.12 12.89 12.17 8.23 5.85 4.22 3.95 25.05%
EPS 1.45 1.07 1.00 0.47 0.61 0.78 1.11 4.55%
DPS 0.69 0.44 0.72 0.72 0.58 0.58 0.58 2.93%
NAPS 0.5229 0.2183 0.4814 0.464 0.1973 0.1862 0.1948 17.87%
Price Multiplier on Financial Quarter End Date
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Date 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 -
Price 1.37 1.30 2.25 2.04 2.65 2.97 2.38 -
P/RPS 6.23 2.94 5.36 7.19 6.57 10.15 8.70 -5.41%
P/EPS 65.16 35.20 65.02 126.38 63.25 54.90 30.91 13.22%
EY 1.53 2.84 1.54 0.79 1.58 1.82 3.24 -11.74%
DY 0.73 1.15 1.11 1.23 1.51 1.35 1.68 -12.96%
P/NAPS 1.80 1.73 1.36 1.28 1.95 2.30 1.76 0.37%
Price Multiplier on Announcement Date
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Date 30/08/19 26/11/18 25/08/17 22/08/16 25/08/15 26/08/14 28/08/13 -
Price 1.41 1.08 2.03 2.14 2.40 3.37 2.44 -
P/RPS 6.42 2.44 4.84 7.54 5.95 11.52 8.92 -5.33%
P/EPS 67.06 29.25 58.66 132.57 57.28 62.29 31.69 13.30%
EY 1.49 3.42 1.70 0.75 1.75 1.61 3.16 -11.77%
DY 0.71 1.39 1.23 1.17 1.67 1.19 1.64 -13.01%
P/NAPS 1.86 1.44 1.22 1.34 1.76 2.61 1.81 0.45%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment